RIV.V - Canopy Rivers Inc.

TSXV - TSXV Delayed Price. Currency in CAD
2.3900
-0.1100 (-4.40%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close2.5000
Open2.5400
Bid2.3900 x 0
Ask2.4200 x 0
Day's Range2.3650 - 2.5900
52 Week Range0.1550 - 6.3300
Volume196,427
Avg. Volume348,530
Market Cap447.073M
Beta (3Y Monthly)N/A
PE Ratio (TTM)119.50
EPS (TTM)0.0200
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.52
  • Canopy Rivers' thriving ecosystem demonstrated by purchase and supply agreement between portfolio companies
    CNW Group

    Canopy Rivers' thriving ecosystem demonstrated by purchase and supply agreement between portfolio companies

    JWC AND TERRASCEND SIGN MUTUALLY BENEFICIAL PURCHASE AND SUPPLY CONTRACT TORONTO , Aug.15, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company" ) (TSXV: RIV) (OTC: CNPOF) ...

  • Canopy Rivers to Report First Quarter Fiscal Year 2020 Financial Results and Host Earnings Call
    CNW Group

    Canopy Rivers to Report First Quarter Fiscal Year 2020 Financial Results and Host Earnings Call

    TORONTO, Aug. 13, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) will report its first quarter fiscal year 2020 financial results before markets open on Tuesday, August 27, 2019. The Company's unaudited condensed interim financial statements and Management's Discussion and Analysis for the three months ended June 30, 2019 will be available on the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at www.canopyrivers.com/investors/financials-and-public-filings. Certain preliminary financial information pertaining to the Company may also be found in the financial results released by Canopy Growth Corporation (TSX:WEED.TO - News) (NYSE:CGC - News), which are currently scheduled to be released on August 14, 2019.

  • Canopy Rivers receives conditional approval to graduate to the Toronto Stock Exchange
    CNW Group

    Canopy Rivers receives conditional approval to graduate to the Toronto Stock Exchange

    TORONTO, Aug. 12, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to announce that it has received conditional approval from the Toronto Stock Exchange (the "TSX") to graduate from the TSX Venture Exchange (the "TSXV") and list its class A subordinated voting shares (the "Subordinated Voting Shares") on the TSX.

  • Market Exclusive

    Canopy Rivers Gets Approval to Expand Ontario’s Production Facility

    Canopy Rivers (TSXV: RIV) (OTC: CNPOF) announced that its portfolio company Radicle Medical Marijuana received approval from Health Canada to expand its production facility in Ontario. The approval will help the company to effectively double its production, increasing its capacity to 6,000 kilograms per year. With the Health Canada approval, Radicle will have 40,000 sq. […]The post Canopy Rivers Gets Approval to Expand Ontario’s Production Facility appeared first on Market Exclusive.

  • Cannabis Investors: The One Stock That All Investors Should Own
    The Motley Fool

    Cannabis Investors: The One Stock That All Investors Should Own

    Canopy Rivers Inc (TSXV:RIV) the venture capital arm of Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has a unique business model that ensures it will grow along with the cannabis industry.

  • Canopy Rivers Portfolio Company YSS Receives 12th Cannabis Retail Licence in Alberta
    CNW Group

    Canopy Rivers Portfolio Company YSS Receives 12th Cannabis Retail Licence in Alberta

    TORONTO, Aug. 8, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) congratulates its portfolio company, YSS Corp. ("YSS") (TSXV:YSS) (WKN:A2PMAX), on receiving its 12th cannabis retail licence from the Alberta Gaming, Liquor and Cannabis Commission ("AGLC"). Operating under the YSS™ brand name, the newly licensed store is strategically located in a high-traffic suburban area in northwest Edmonton. YSS has six operational stores located in Calgary and Red Deer, with an additional two licensed locations expected to open in Vermilion and Vegreville within the next week.

  • Canopy Rivers Portfolio Company Terrascend Announces Acquisition of Vertically-Integrated Pennsylvania Cannabis Operator
    CNW Group

    Canopy Rivers Portfolio Company Terrascend Announces Acquisition of Vertically-Integrated Pennsylvania Cannabis Operator

    TORONTO, Aug. 6, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to announce its portfolio company, TerrAscend Corp. ("TerrAscend") (CSE:TER.CN - News) (OTCQX:TRSSF - News), has signed a definitive agreement to acquire Ilera Healthcare ("Ilera"), a vertically-integrated cannabis cultivator, processor, and dispensary operator in Pennsylvania. Ilera's state-of-the-art, fully integrated seed-to-sale operations adds to TerrAscend's growing global footprint, currently spanning multiple U.S. states, Canada and the European Union. "TerrAscend's rapid expansion in the U.S. has been driven by strategic, accretive acquisitions of quality operators with strong track records of success," said Narbe Alexandrian, President and CEO of Canopy Rivers.

  • Canopy Rivers Announces Health Canada Approval for Significant Expansion to the Licensed Infrastructure at Radicle
    CNW Group

    Canopy Rivers Announces Health Canada Approval for Significant Expansion to the Licensed Infrastructure at Radicle

    TORONTO, Aug. 1, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to announce that its portfolio company Radicle Medical Marijuana Inc. ("Radicle") has received approval from Health Canada for its production facility expansion project. This approval effectively doubles Radicle's production footprint, significantly increasing its capacity to 6,000 kilograms per year. "We are thrilled with the continued growth happening at Radicle," said Narbe Alexandrian, President and CEO of Canopy Rivers.

  • Canopy Rivers' Flagship PharmHouse JV Licensed By Health Canada
    CNW Group

    Canopy Rivers' Flagship PharmHouse JV Licensed By Health Canada

    TORONTO, July 22, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to announce that its 49%-owned joint venture, PharmHouse Inc.  ("PharmHouse"), has received a cultivation licence from Health Canada. PharmHouse will be immediately commencing operations in 190,000 sq. ft. of licensed nursery infrastructure and plans to ramp up the entire 1.3 million sq. ft. ultramodern greenhouse before the end of 2019 to deliver low-cost and high-quality cannabis and cannabis derivative products to the Canopy Rivers ecosystem of partners, both domestically and internationally. "This is a significant corporate milestone for Canopy Rivers.

  • Could This Canopy Growth (TSX:WEED) Spin-Off Be a Great Buy?
    The Motley Fool

    Could This Canopy Growth (TSX:WEED) Spin-Off Be a Great Buy?

    Canopy Rivers Inc. (TSXV:RIV) has an interesting business strategy and could benefit substantially from the growing marijuana market. But is it a buy right now?

  • Cannabis venture capital firm Canopy Rivers reports $1.8-million Q4 loss
    The Canadian Press

    Cannabis venture capital firm Canopy Rivers reports $1.8-million Q4 loss

    Canopy Rivers Inc., the venture capital arm of cannabis company Canopy Growth Corp., swung to a loss in its latest quarter as its operating expenses soared. The Toronto-based firm reported Tuesday a loss of $1.8 million in the three months ended March 31 compared with a profit of nearly $14.6 million in the same quarter last year. Canopy Rivers said as positive global sentiment towards pot rises and Canada legalizes edibles, topicals and extracts, there is growth potential for the industry and ancillary businesses which do not touch the plant.

  • Canopy Rivers Reports Fourth Quarter and Fiscal Year 2019 Financial Highlights and Provides Corporate Update
    CNW Group

    Canopy Rivers Reports Fourth Quarter and Fiscal Year 2019 Financial Highlights and Provides Corporate Update

    TORONTO, July 16, 2019 /CNW/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSXV:RIV.V - News) (OTC:CNPOF - News) today released its financial results for the three and twelve months ended March 31, 2019. The Company's audited consolidated financial statements for the twelve months ended March 31, 2019, and its full Management's Discussion and Analysis (the "MD&A") for the three and twelve months ended March 31, 2019, are available under the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at www.canopyrivers.com/financials. "It was a year full of milestones and significant achievements for Canopy Rivers," said Narbe Alexandrian, President and Chief Executive Officer of Canopy Rivers.

  • Market Exclusive

    Cannabis Stock News Daily Roundup July 10

    Zenabis Global (OTCMKTS:ZBISF) has submitted its site evidence package to Health Canada for the first phase of its facility in Langley. Called Zenabis Langley, the facility’s first 50,000 sq. ft. flower room is substantially complete, while work on the remaining five flower rooms and additional support space, totaling 380,000 sq. ft., is set to complete […]The post Cannabis Stock News Daily Roundup July 10 appeared first on Market Exclusive.

  • Canopy Rivers portfolio company YSS receives five new cannabis retail licences in Alberta
    CNW Group

    Canopy Rivers portfolio company YSS receives five new cannabis retail licences in Alberta

    TORONTO , July 9, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSXV: RIV) (OTC: CNPOF) congratulates its portfolio company, YSS Corp. (" YSS ") ...

  • Canopy Rivers Portfolio Company Receives Key Licence Amendment from Health Canada
    CNW Group

    Canopy Rivers Portfolio Company Receives Key Licence Amendment from Health Canada

    TORONTO, July 8, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to share that its portfolio company, James E. Wagner Cultivation Corporation ("JWC") (TSXV:JWCA.V - News) (OTCQX:JWCAF - News), has received approval of a licence amendment from Health Canada. This licence amendment allows for the sale of formulated cannabis oil from JWC's pilot facility in Kitchener, Ontario.

  • Canopy Rivers Portfolio Company Terrascend Receives Cannabis Oil Sales Licence in Canada
    CNW Group

    Canopy Rivers Portfolio Company Terrascend Receives Cannabis Oil Sales Licence in Canada

    TORONTO , July 8, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSXV: RIV) (OTC: CNPOF) congratulates its portfolio company TerrAscend Corp. (" TerrAscend ...

  • Market Exclusive

    Cannabis Stock News Daily Roundup July 5

    Cannabis Stock News The Cannabis Council of Canada (C3) applauded the Government of Ontario for their decision to expand adult use retail cannabis licenses. With national cannabis supply levels improving, C3 believes that the continued and sustained expansion of Ontario's retail network will be a key factor in replacing the illicit cannabis market with a legal […]The post Cannabis Stock News Daily Roundup July 5 appeared first on Market Exclusive.

  • CNW Group

    Canopy Rivers Announces Change to Board of Directors

    TORONTO , July 3, 2019 /CNW/ - Further to Canopy Growth Corporation's press release today, Bruce Linton has also stepped down as Chairman and Director of Canopy Rivers Inc. (the "Company" or ...

  • CNW Group

    Canopy Rivers to Report Fourth Quarter and Fiscal Year 2019 Financial Results

    TORONTO, June 19, 2019 /CNW/ - Canopy Rivers Inc. (the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) will report its financial results for the fourth quarter and fiscal year ended March 31, 2019 before markets open on Tuesday, July 16, 2019. The Company's audited consolidated financial statements and Management's Discussion and Analysis for the three and twelve months ended March 31, 2019 will be available on the Company's profile on SEDAR at www.sedar.com and in the Investors section of the Company's website at www.canopyrivers.com. Certain preliminary financial information pertaining to the Company may also be found in the financial results released by Canopy Growth Corporation (TSX: WEED, NYSE: CGC), which are currently scheduled to be released on June 20, 2019.

  • Canopy Rivers Makes US$10 Million Investment in Plant Genetics Innovator ZeaKal
    CNW Group

    Canopy Rivers Makes US$10 Million Investment in Plant Genetics Innovator ZeaKal

    TORONTO and SAN DIEGO, June 19, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers", the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) and ZeaKal, Inc. ("ZeaKal") are pleased to announce an investment and strategic collaboration between Canopy Rivers and ZeaKal, a California-based plant science innovator with proprietary technologies that sustainably increase photosynthesis, improve plant yield and enhance nutritional profiles for a variety of agricultural crops. The investment from Canopy Rivers marks another significant corporate milestone this calendar year for ZeaKal, following the February announcement of its R&D collaboration (link) with Corteva Agriscience (NYSE:CTVA), the recently spun-out and NYSE-listed agricultural science division of DowDuPont.

  • CNW Group

    Canopy Rivers announces grant of options

    TORONTO , June 13, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSXV: RIV) (OTC: CNPOF) has granted incentive stock options under the Company's stock option ...

  • Market Exclusive

    Agripharm Wins Approval for Outdoor Cultivation License

    Canopy Rivers (TSXV: RIV) (OTC: CNPOF) announced that its portfolio company Agripharm Corp. received its outdoor cultivation license from Health Canada. Agripharm is co-owned by SLANG (CNSX: SLNG), Canopy Growth (NYSE: CGC) and Green House Holdings North America and received a strategic investment from Canopy Rivers. Canopy Rivers provided the capital to finance the build-out […]The post Agripharm Wins Approval for Outdoor Cultivation License appeared first on Market Exclusive.

  • Canopy Rivers Hosts Analyst and Investor Day on May 28 - Live Webcast Available
    CNW Group

    Canopy Rivers Hosts Analyst and Investor Day on May 28 - Live Webcast Available

    TORONTO, May 28, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News), (OTC:CNPOF - News) will be hosting its analyst and investor day from 1:00 p.m. to 5:00 p.m. ET today, May 28. The webcast will be available on Canopy Rivers' website immediately prior to the event at www.canopyrivers.com/investors/events. Bruce Linton, Chairman of the Board, will share his perspective on Canopy Rivers' unique value proposition.  This will be followed by a presentation from senior executives addressing Canopy Rivers' priorities in support of its mission to accelerate success in the global cannabis economy.

  • CNW Group

    Canopy Growth subsidiary and Canopy Rivers portfolio company Vert Mirabel now fully licensed by Health Canada

    Final 190,000 sq. ft. Greenhouse Licensed. Total of 700,000 sq. ft. of Production and Processing Infrastructure Now Fully Licensed MIRABEL, QC , May 28, 2019 /CNW/ - Les Serres Vert Cannabis Inc. ("Vert ...

  • Canopy Rivers Hosts analyst and Investor Day
    CNW Group

    Canopy Rivers Hosts analyst and Investor Day

    TORONTO , May 23, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSXV: RIV) (OTC: CNPOF) today announced that it will host an analyst and investor day on Tuesday, ...